Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Genomics and Personalized Medicine Act of 2010
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · first_quarter · 1A
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2010 · second_quarter · Q2
Source: Senate LDA
| ACADEMY OF MOLECULAR IMAGING |
| 6 |
| 2008–2009 |
| CUBIST PHARMACEUTICALS | 6 | 2007–2008 |
| GILEAD SCIENCES, INC. | 5 | 2007–2008 |
| XDX INC | 3 | 2008–2009 |
| CALYPSO MEDICAL TECHNOLOGIES, INC. | 1 | 2007 |
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory- developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act H.R. 3590
Patient Access to Critical Lab Tests Act
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory- developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
FDA Globalization Act, HR759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S301
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
Food and Drug Administration Globalization Act of 2009
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Food and Drug Administration Globalization Act of 2009
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR759 Medicare Improvement Patients and Providers Act - HR 6331
Food and Drug Administration Globalization Act of 2009
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S301
A bill to extend temporarily the suspension of duty on Acetoacet-o-Chloro Anilide.
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
FDA Globalization Act, HR759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S301
A bill to provide that certain provisions of subchapter I of chapter 35 of title 44, United States Code, relating to Federal information policy shall not apply to the collection of information during any investigation, audit, inspection, evaluation, or other review conducted by any Federal office of Inspector General, and for other purposes.
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR759 Medicare Improvement Patients and Providers Act - HR 6331
Non-Prescription Drug Modernization Act of 2007
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Medicare Improvements for Patients and Providers Act of 2008
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR759 Medicare Improvement Patients and Providers Act - HR 6331
Medicare Improvements for Patients and Providers Act of 2008
Client: XDX INC · Firm: FOLEY HOAG LLP
Medicare payment for molecular diagnostics Medicare Improvement for Patients and Providers Act - H.R. 6331
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR759 Medicare Improvement Patients and Providers Act - HR 6331
FDA Globalization Act, HR 3610, S 3409 Follow-on biologics - S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act - S 2029
FDA Globalization Act , HR__, S__ Follow-on Biologics - S 1695, HR 1038, HR 1956 Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act; Physician Payments Sunshine Act - S 2029
FDA Globalization Act, HR 3610, S 3409; Follow-on Biologics - S 1695, HR 1038, HR 1956; Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act Physician Payments Sunshine Act - S 2029
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956; FDA Globalization Act - HR__, S.__
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956 FDA Globalization Act - HR 3610, S 3409
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956 FDA Globalization Act - HR 3610, S 3409
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956; FDA Globalization Act - HR__, S.__
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR 3610, S 3409 Follow-on biologics - S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act - S 2029
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act , HR__, S__ Follow-on Biologics - S 1695, HR 1038, HR 1956 Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act; Physician Payments Sunshine Act - S 2029
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR 3610, S 3409; Follow-on Biologics - S 1695, HR 1038, HR 1956; Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act Physician Payments Sunshine Act - S 2029
Food and Drug Administration Amendments Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 976, S. 736, FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580
Food and Drug Administration Amendments Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 976, S. 736, FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580
Food and Drug Administration Amendments Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 976, S. 736, FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580
Food and Drug Administration Amendments Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 976, S. 736, FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580
Food and Drug Import Safety Act of 2007
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Food and Drug Import Safety Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR 3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Food and Drug Import Safety Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Food and Drug Import Safety Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Food and Drug Import Safety Act of 2007
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Food and Drug Import Safety Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
FDA Globalization Act, HR 3610, S 3409; Follow-on Biologics - S 1695, HR 1038, HR 1956; Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act Physician Payments Sunshine Act - S 2029
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956 FDA Globalization Act - HR 3610, S 3409
Ryan White AIDS Care Act and federal HIV/AIDS policy FDA Globalization Act- HR 3610, S 3409
FDA Globalization Act, HR 3610, S 3409 Follow-on biologics - S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act - S 2029
Food and Drug Import Safety Act of 2007
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Food and Drug Import Safety Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Strategies to Address Antimicrobial Resistance Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Bio-medical research Food and Drug Issues MRSA Awareness Month Resolution, S. 454, H.R. 988; STAAR Act, HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Strategies to Address Antimicrobial Resistance Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR__, S.__ MRSA Awareness Month Resolution - S. 454, H.R. 988 STAAR Act - HR 3697, S 2313 CHAIR Act - HR 4214, S 2278
Strategies to Address Antimicrobial Resistance Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Strategies to Address Antimicrobial Resistance Act
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Strategies to Address Antimicrobial Resistance Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Strategies to Address Antimicrobial Resistance Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Strategies to Address Antimicrobial Resistance Act
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Non-Prescription Drug Modernization Act of 2007
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR___, S____
Non-Prescription Drug Modernization Act of 2007
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Non-Prescription Drug Modernization Act of 2007
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR__, S.__ MRSA Awareness Month Resolution - S. 454, H.R. 988 STAAR Act - HR 3697, S 2313 CHAIR Act - HR 4214, S 2278
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Bio-medical research Food and Drug Issues MRSA Awareness Month Resolution, S. 454, H.R. 988; STAAR Act, HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act , HR__, S__ Follow-on Biologics - S 1695, HR 1038, HR 1956 Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act; Physician Payments Sunshine Act - S 2029
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956 FDA Globalization Act - HR 3610, S 3409
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956; FDA Globalization Act - HR__, S.__
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR 3610, S 3409; Follow-on Biologics - S 1695, HR 1038, HR 1956; Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act Physician Payments Sunshine Act - S 2029
Medicare Improvements for Patients and Providers Act of 2008
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Medicare Improvements for Patients and Providers Act - H.R. 6331
Medicare Improvements for Patients and Providers Act of 2008
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR_, S.__ Medicare Improvement Patients and Providers Act - HR 6331
Medicare Improvements for Patients and Providers Act of 2008
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR 3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Medicare Improvements for Patients and Providers Act of 2008
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Medicare Improvements for Patients and Providers Act of 2008
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Medicare Improvements for Patients and Providers Act - H.R. 6331
Medicare Improvements for Patients and Providers Act of 2008
Client: COALITION FOR THE 21ST CENTURY · Firm: FOLEY HOAG LLP
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
To designate the facility of the United States Postal Service located at 5757 Tilton Avenue in Riverside, California, as the "Lieutenant Todd Jason Bryant Post Office".
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
To designate the facility of the United States Postal Service located at 5757 Tilton Avenue in Riverside, California, as the "Lieutenant Todd Jason Bryant Post Office".
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
To designate the facility of the United States Postal Service located at 5757 Tilton Avenue in Riverside, California, as the "Lieutenant Todd Jason Bryant Post Office".
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
To designate the facility of the United States Postal Service located at 5757 Tilton Avenue in Riverside, California, as the "Lieutenant Todd Jason Bryant Post Office".
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Bio-medical research Food and Drug Issues MRSA Awareness Month Resolution, S. 454, H.R. 988; STAAR Act, HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
To designate the facility of the United States Postal Service located at 5757 Tilton Avenue in Riverside, California, as the "Lieutenant Todd Jason Bryant Post Office".
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR__, S.__ MRSA Awareness Month Resolution - S. 454, H.R. 988 STAAR Act - HR 3697, S 2313 CHAIR Act - HR 4214, S 2278
Designating the month of March 2008 as "MRSA Awareness Month".
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Designating the month of March 2008 as "MRSA Awareness Month".
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Biologics Price Competition and Innovation Act of 2007
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956 FDA Globalization Act - HR 3610, S 3409
Biologics Price Competition and Innovation Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR 3610, S 3409 Follow-on biologics - S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act - S 2029
Biologics Price Competition and Innovation Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act , HR__, S__ Follow-on Biologics - S 1695, HR 1038, HR 1956 Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act; Physician Payments Sunshine Act - S 2029
Biologics Price Competition and Innovation Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR 3610, S 3409; Follow-on Biologics - S 1695, HR 1038, HR 1956; Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act Physician Payments Sunshine Act - S 2029
Biologics Price Competition and Innovation Act of 2007
Client: GILEAD SCIENCES INC · Firm: FOLEY HOAG LLP
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956; FDA Globalization Act - HR__, S.__
Biologics Price Competition and Innovation Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Food and Drug Legislation Follow-on Biologics - S 1695 Global Health legislation
FDA Globalization Act, HR 3610, S 3409 Follow-on biologics - S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act - S 2029
FDA Globalization Act, HR 3610, S 3409; Follow-on Biologics - S 1695, HR 1038, HR 1956; Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act Physician Payments Sunshine Act - S 2029
FDA Globalization Act , HR__, S__ Follow-on Biologics - S 1695, HR 1038, HR 1956 Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act; Physician Payments Sunshine Act - S 2029
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR__, S.__ MRSA Awareness Month Resolution - S. 454, H.R. 988 STAAR Act - HR 3697, S 2313 CHAIR Act - HR 4214, S 2278
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Bio-medical research Food and Drug Issues MRSA Awareness Month Resolution, S. 454, H.R. 988; STAAR Act, HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: BECTON DICKINSON AND COMPANY · Firm: FOLEY HOAG LLP
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Community and Healthcare-Associated Infections Reduction Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory-developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152);Genomics & Personalized Medicine Act H.R. 5440
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2010 · first_quarter · Q1
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues; Regulation of laboratory- developed tests; Patient Access to Critical Lab Tests Act S. 1220; Patient Protection and Affordable Care Act H.R. 3590
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2009 · second_quarter · 2@
Medicare coverage of PET scans for cancer indicators
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2009 · second_quarter · 2A
Medicare coverage of PET scans for cancer indicators
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2009 · second_quarter · Q2
Oversight of and reimbursement for molecular diagnostics and other personalized medicine issues Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR759 Medicare Improvement Patients and Providers Act - HR 6331
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2009 · second_quarter · Q2
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Q2
Medicare payment for molecular diagnostics Medicare Improvement for Patients and Providers Act - H.R. 6331
Filing targets: SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2009 · second_quarter · Q2
Medicare coverage of PET scans for cancer indicators
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Q1
Medicare payment for molecular diagnostics
Filing targets: SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2009 · first_quarter · Q1
Medicare Payment for Diabetes screening; Healthcare Reform and Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2009 · first_quarter · Q1
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · first_quarter · Q1
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections
Matters relating to healthcare associated infections
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2009 · first_quarter · Q1
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2009 · first_quarter · Q1
Medicare coverage of PET scans for cancer indicators
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2009 · first_quarter · Q1
FDA Globalization Act, HR759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · second_quarter · 2A
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · first_quarter · 1A
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · third_quarter · 3A
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · second_quarter · Q2
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · first_quarter · Q1
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · third_quarter · 3A
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
Medicare coverage of PET scans for cancer indications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2008 · fourth_quarter · RA
Medicare coverage of PET scans for cancer indications
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2008 · fourth_quarter · 4A
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2008 · fourth_quarter · 4A
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
Medicare Payment for Diabetes screening
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Q4
Molecular diagnostic medicare payment and coverage
Filing targets: SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
Ryan White AIDS Care Act and federal HIV/AIDS policy FDA Globalization Act- HR 3610, S 3409
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
FDA Globalization Act, HR 3610, S 3409 Follow-on biologics - S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act - S 2029
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
Legislative modification of the Medicare Laboratory Fee Schedule
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2008 · fourth_quarter · Q4
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · third_quarter · 3A
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · third_quarter · Q3
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2008 · third_quarter · Q3
Medicare Improvements for Patients and Providers Act - H.R. 6331
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956 FDA Globalization Act - HR 3610, S 3409
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2008 · third_quarter · Q3
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR 3610, S 3409 Medicare Improvement Patients and Providers Act - HR 6331
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2008 · third_quarter · Q3
Medicare Payment for Diabetes screening
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2008 · third_quarter · Q3
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2008 · third_quarter · Q3
FDA Globalization Act - HR 3610, S 3409; MRSA Awareness Month Resolution - S. 454, H.R. 988; STAAR Act - HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2008 · second_quarter · Q2
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2008 · third_quarter · Q3
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2008 · third_quarter · Q3
FDA Globalization Act, HR 3610, S 3409; Follow-on Biologics - S 1695, HR 1038, HR 1956; Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act Physician Payments Sunshine Act - S 2029
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2008 · second_quarter · Q2
Medicare Payment for Diabetes screening
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2008 · second_quarter · Q2
Ryan White AIDS Care Act; Global Health Issues - HR 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act; Follow-on Biologics: S 1695, HR 1038, HR 1956; FDA Globalization Act - HR__, S.__
Medicare Improvements for Patients and Providers Act - H.R. 6331
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2008 · second_quarter · Q2
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR___, S____
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · second_quarter · Q2
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2008 · second_quarter · Q2
FDA Globalization Act - HR__, S.__ MRSA Awareness Month Resolution - S. 454, H.R. 988 STAAR Act - HR 3697, S 2313 CHAIR Act - HR 4214, S 2278
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2008 · second_quarter · Q2
Regulation of laboratory-developed tests S. 736, Labaratory Test Improvement Act. S. 976, Geonomics and Personalized Medicare Act FDA Globalization Act, HR_, S.__ Medicare Improvement Patients and Providers Act - HR 6331
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2008 · second_quarter · Q2
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2008 · second_quarter · Q2
FDA Globalization Act , HR__, S__ Follow-on Biologics - S 1695, HR 1038, HR 1956 Global health legislation - H.R. 5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act; Physician Payments Sunshine Act - S 2029
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2008 · first_quarter · Q1
Ryan White AIDS Care Act; PEPFAR Reauthorization Global Health Issues
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2008 · first_quarter · RA
FDA drug regulatory issues
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2008 · first_quarter · RR
FDA drug regulatory issues
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2008 · first_quarter · Q1
FDA drug regulatory issues
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2008 · first_quarter · 1A
Regulation of laboratory-developed tests S. 976, S. 736, FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2008 · first_quarter · Q1
Bio-medical research Food and Drug Issues MRSA Awareness Month Resolution, S. 454, H.R. 988; STAAR Act, HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2008 · first_quarter · Q1
Regulation of laboratory-developed tests S. 976, S. 736, FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2008 · first_quarter · Q1
Matters affecting research, diagnosis, treatment and prevention of breast cancer.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2008 · first_quarter · Q1
Medicare payment for diabetes screening tests CHAMP Act, HR 3162 SCHIP Extension Act, S 2499
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2008 · first_quarter · Q1
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; S. Res. 454, H. Res 988, S. 2278,H.R. 4214, H.R. 3697, S. 2313
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2008 · first_quarter · Q1
Food and Drug Legislation Follow-on Biologics - S 1695 Global Health legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2008 · first_quarter · RR
FDA drug regulatory issues
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2007 · year_end · YA
Matters affecting research, diagnosis, treatment, and prevention of breast cancer. National Breast and Cervical Cancer Early Detection Program Reauthorization -- S 624, HR 1132; Department of Defense Appropriations Act -- HR 3222; Departments of Labor, Health and Human Services and Education Appropriations Act -- S 1710, HR 3043.
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2007 · year_end · YY
Matters affecting research, diagnosis, treatment, and prevention of breast cancer. National Breast and Cervical Cancer Early Detection Program Reauthorization -- S 624, HR 1132; Department of Defense Appropriations Act -- HR 3222; Departments of Labor, Health and Human Services and Education Appropriations Act -- S 1710, HR 3043.
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2007 · year_end · YY
Medicare payment for diabetes screening tests CHAMP Act, HR 3162 SCHIP Extension Act, S 2499
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2007 · year_end · YY
Matters affecting research, diagnosis, treatment, and prevention of breast cancer. National Breast and Cervical Cancer Early Detection Program Reauthorization -- S 624, HR 1132; Department of Defense Appropriations Act -- HR 3222; Departments of Labor, Health and Human Services and Education Appropriations Act -- S 1710, HR 3043.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2007 · year_end · YY
Bio-medical research Food and Drug Issues FDA Drug Safety Legislation--FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580 Bird Act, HR 1496; STAAR Act, HR 3697, S 2313; CHAIR Act, HR 4214, S 2278
Medicare coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR THE 21ST CENTURY via FOLEY HOAG LLP
2007 · year_end · YY
Regulation of laboratory-developed tests S. 976, S. 736, FDA Amendments Act of 2007, S 1082, HR 2900, HR 3580
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CALYPSO MEDICAL TECHNOLOGIES INC via FOLEY HOAG LLP
2007 · year_end · YY
Medicare payment for devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2007 · year_end · YY
Federal policies regarding utilization of diagnostic products and medical equipment; hospital-acquired infections; FDA reauthorization. FDA bills (S 1082, HR 2900); SB. 2278, 549, 2351, 654, 2525, 2526, and 2313; HR 962, 3697, 4214, 4200, 1148, 4451,1174, 4352, and 1496
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2007 · year_end · YY
Food and Drug Legislation - S 1082, HR 2900 Follow-on Biologics - S 1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2007 · year_end · YY
Ryan White AIDS Care Act; PEPFAR Reauthorization Global Health Issues Food and Drug Administration -- S 1082, HR 2900
Medicare coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2007 · year_end · RR
Medicare payment for diabetes screening tests H.R. 3162, the Children's Health and Medicare Protection Act of 2007 (CHAMP)
Medicare payment for diabetes screening tests H.R. 3162, the Children's Health and Medicare Protection Act of 2007 (CHAMP)
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2007 · mid_year · MM
National Breast and Cervical Cancer Early Detection Program Reauthorization--S 624, HR 1132 Department of Defense Appropriations Act--HR 3222 Departments of Labor, Health and Human Services and Education Appropriations Act--S 1710, HR 3043
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2007 · year_end · RA
Cancer legislation issues
Cancer legislation issues